2007
DOI: 10.1007/s00018-007-7171-2
|View full text |Cite
|
Sign up to set email alerts
|

Biosynthesis, immunity, regulation, mode of action and engineering of the model lantibiotic nisin

Abstract: This review discusses the state-of-the-art in molecular research on the most prominent and widely applied lantibiotic, i.e., nisin. The developments in understanding its complex biosynthesis and mode of action are highlighted. Moreover, novel applications arising from engineering either nisin itself, or from the construction of totally novel dehydrated and/or lanthionine-containing peptides with desired bioactivities are described. Several challenges still exist in understanding the immunity system and the uni… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

3
332
4
3

Year Published

2010
2010
2020
2020

Publication Types

Select...
5
2
1

Relationship

0
8

Authors

Journals

citations
Cited by 303 publications
(349 citation statements)
references
References 108 publications
3
332
4
3
Order By: Relevance
“…Static time-kill studies assessed nisin (4,8,32, and 128 mg/liter), amikacin (1,4,16, and 64 mg/liter), and linezolid (2, 8, and 32 mg/liter) in monotherapy.…”
Section: Methodsmentioning
confidence: 99%
See 2 more Smart Citations
“…Static time-kill studies assessed nisin (4,8,32, and 128 mg/liter), amikacin (1,4,16, and 64 mg/liter), and linezolid (2, 8, and 32 mg/liter) in monotherapy.…”
Section: Methodsmentioning
confidence: 99%
“…The bacterial pellets were immediately resuspended in prewarmed broth containing no antibiotic (control), 8 or 16 mg/liter amikacin, or 8 or 32 mg/liter linezolid at approximately 1.75 h. In addition to the sequential combinations with pretreatment by nisin, simultaneous combinations also were studied, where the bacteria were simultaneously exposed to nisin plus amikacin or nisin plus linezolid throughout the whole experiment. The simultaneously dosed combinations were studied for selected informative combinations of nisin (8,16, and 32 mg/liter) with amikacin (4, 8, and 16 mg/ liter) or linezolid (2,8, and 32 mg/liter).…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…6 Nisin also shows considerable promise as a human therapeutic, especially for the treatment of drug-resistant bacterial infections. 7 As nisin SAR studies have been extensively reviewed, 4,6,7,11,12 we have chosen to limit this discussion to several recent studies.…”
Section: Nisinmentioning
confidence: 99%
“…Some of these are also applied as food preservatives such as nisin, which is a potent antibacterial 34 amino acid peptide containing a number of uncommon amino acids. Nisin has been employed as an approved food preservative in cheese , fish, meat, and beverages (reviewed in Lubelski et al, 2008). Another known antimicrobial peptide is -poly-L-lysine which exhibits antimicrobial activity against bacteria and fungi and is used as a food preservative (reviewed in Hamano, 2011).…”
Section: Shelf Lifementioning
confidence: 99%